These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9490330)
21. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city. Caballero-Uribe CV; Acosta-Velez JG; Hernandez-Ruiz EA; Andrade Rodado FM; Peñuela-Epalza M J Clin Rheumatol; 2008 Jun; 14(3):153-5. PubMed ID: 18525434 [TBL] [Abstract][Full Text] [Related]
22. [Letter query to Zeitschrift für Rheumatologie by Dr. med. Ilka Schwarze FA of Internal Medicine and Rheumatology Center of Internal Medicine--Leipzig University Clinic]. Scharla S Z Rheumatol; 2005 Mar; 64(2):138-9. PubMed ID: 15793680 [No Abstract] [Full Text] [Related]
24. [Comment on the article "Characteristics of patients with osteopenia treated with glucocorticoids at the Osteoporosis Clinic of the Medical Faculty Hospital in Hradec Kralove"]. Horák P Vnitr Lek; 2003 Jan; 49(1):10-1. PubMed ID: 12666422 [No Abstract] [Full Text] [Related]
25. Glucocorticoid-related cardiovascular and cerebrovascular events in rheumatic diseases: myth or reality? Gonzalez-Gay MA Arthritis Rheum; 2007 Mar; 57(2):191-2. PubMed ID: 17330291 [No Abstract] [Full Text] [Related]
26. Corticosteroid-induced osteoporosis in neurology patients. Gallagher DA; Sturrock A Clin Neurol Neurosurg; 2007 Feb; 109(2):218-9. PubMed ID: 16949735 [No Abstract] [Full Text] [Related]
27. Is there cyclosporine A-induced bone disease? Callegari PE Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):103S-106S. PubMed ID: 9273950 [No Abstract] [Full Text] [Related]
28. The epidemiology of glucocorticoid-associated adverse events. McDonough AK; Curtis JR; Saag KG Curr Opin Rheumatol; 2008 Mar; 20(2):131-7. PubMed ID: 18349741 [TBL] [Abstract][Full Text] [Related]
29. Quantifying risks: the case between glucocorticoids and tuberculosis. Carmona L Arthritis Rheum; 2006 Feb; 55(1):1-2. PubMed ID: 16463392 [No Abstract] [Full Text] [Related]
30. Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science. Abadie EC; Devogealer JP; Ringe JD; Ethgen DJ; Bouvenot GM; Kreutz G; Laslop A; Orloff JJ; Vanderauwera PM; Delmas PD; Dere WH; Branco J; Altman RD; Avouac BP; Menkes CJ; Vanhaelst L; Mitlak BH; Tsouderos Y; Reginster JY Semin Arthritis Rheum; 2005 Aug; 35(1):1-4. PubMed ID: 16084217 [TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid-induced osteoporosis in inflammatory bowel disease. Lidofsky S; Smith J Med Health R I; 2009 Apr; 92(4):128-30. PubMed ID: 19452756 [TBL] [Abstract][Full Text] [Related]
32. Deflazacort in pediatric rheumatic diseases needs a frequent follow-up of bone densitometry. Falcini F; Trapani S; Ermini M; Bartolozzi G Pediatrics; 1995 Feb; 95(2):318. PubMed ID: 7838659 [No Abstract] [Full Text] [Related]
33. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate]. Benucci M; Dolenti S; Saviola G; Manfredi M Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926 [TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids in patients with rheumatic diseases: friends or enemies of bone? Ciccarelli F; De Martinis M; Ginaldi L Curr Med Chem; 2015; 22(5):596-603. PubMed ID: 25386817 [TBL] [Abstract][Full Text] [Related]
35. [Treatment with corticosteroids, bone mineral density and risk of fractures]. Rosa J Vnitr Lek; 2003 Jan; 49(1):12-4. PubMed ID: 12666423 [No Abstract] [Full Text] [Related]
36. [Glucocorticoids in rheumatology]. Sörensen H Med Klin (Munich); 1993 Jan; 88 Suppl 1():13-4. PubMed ID: 8437534 [No Abstract] [Full Text] [Related]